Skip to main content
Premium Trial:

Request an Annual Quote

Guava Technologies Raises $7M in Venture Capital, Names New CEO

NEW YORK, Nov. 29 (GenomeWeb News) - Guava Technologies has raised $7 million in private-equity financing and has promoted Lawrence Bruder, the company's president and chief operating officer, to chief operating officer, the firm said today.


The venture capital was raised by existing investors Abingworth Life Science Investment, Granite Global Ventures, HLM Venture Partners, MDS Capital Corp., ProQuest Investments, and Skyline Ventures.

Bruder said the company expects to be cash-flow positive "within 12 months" and attributed the outlook on new products, sales to new customer bases "within the overall cell analysis market," and "penetration of foreign markets."


"The current financing will enable us to continue our growth initiative, bringing us more rapidly to self sufficiency," Bruder said in a statement.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.